News

Shares of biotech companies involved in the development of monoclonal antibody cancer therapies were moving all over the ...
Penpulimab is approved for multiple indications in China, but this marks the first US approval for the novel monoclonal ...
A novel combination therapy offers better outcomes for patients with KRAS G12C metastatic colorectal cancer that have stopped ...
Cancer completely disappeared from two-thirds of 24 patients treated with a combination of the antibody petosemtamab and ...
Verastem Oncology said Wednesday that the Food and Drug Administration cleared the company's investigational new drug application for its potential treatment of certain cancers.
The frequency of high blood glucose among patients receiving PI3K/Akt inhibitors to treat breast cancer has some oncologists ...
Cigna recently changed its policies to cover a popular breast cancer reconstruction treatment that had long been denied.